“Drug Manufacturer’s Risky Practices”

Previously, I have said, “Pharmaceutical companies have egregiously participated in one hundred years of sleazy practices and continue to do so.”  According to a 2013 article in the Journal of Law, Medicine and Ethics (JLME), here is the heart of the problem: about 350 people die daily from drug reactions or 128,000 per year. Pharmaceutical companies hide, ignore, or misrepresent evidence about new drugs; distort the medical literature; and misrepresent products to prescribing physicians. There appears to be an epidemic of harmful allowable Food and Drug Administration (FDA) approved drugs, which have scarce benefits to any patients. A 2018 report shows that Nuplazid, a drug for hallucinations and delusions associated with Parkinson’s disease, failed two clinical trials. In a third trial, under a revised standard for measuring its effect, it showed minimal benefit.  Overall, more patients died or had serious side effects on Nuplazid than after
receiving no treatment.  Also, patients on Uloric, a gout drug, suffered more heart attacks, strokes and heart failure in two out of three trials than did their counterparts on standard or no medication.

Download the complete article (a PDF).